Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results

MLA

Gay, Francesca, et al. “Bortezomib Induction, Reduced-Intensity Transplantation, and Lenalidomide Consolidation-Maintenance for Myeloma: Updated Results.” Blood, vol. 122, no. 8, Aug. 2013, pp. 1376–83. EBSCOhost, https://doi.org/10.1182/blood-2013-02-483073.

APA

Gay, F., Magarotto, V., Crippa, C., Pescosta, N., Guglielmelli, T., Cavallo, F., Pezzatti, S., Ferrari, S., Liberati, A. M., Oliva, S., Patriarca, F., Offidani, M., Omedé, P., Montefusco, V., Petrucci, M. T., Giuliani, N., Passera, R., Pietrantuono, G., Boccadoro, M., … Palumbo, A. (2013). Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. Blood, 122(8), 1376–1383. https://doi.org/10.1182/blood-2013-02-483073

Chicago

Gay, Francesca, Valeria Magarotto, Claudia Crippa, Norbert Pescosta, Tommasina Guglielmelli, Federica Cavallo, Sara Pezzatti, et al. 2013. “Bortezomib Induction, Reduced-Intensity Transplantation, and Lenalidomide Consolidation-Maintenance for Myeloma: Updated Results.” Blood 122 (8): 1376–83. doi:10.1182/blood-2013-02-483073.